MXPA00012577A - Foaming composition for hair care - Google Patents
Foaming composition for hair careInfo
- Publication number
- MXPA00012577A MXPA00012577A MXPA/A/2000/012577A MXPA00012577A MXPA00012577A MX PA00012577 A MXPA00012577 A MX PA00012577A MX PA00012577 A MXPA00012577 A MX PA00012577A MX PA00012577 A MXPA00012577 A MX PA00012577A
- Authority
- MX
- Mexico
- Prior art keywords
- composition according
- composition
- chosen
- alkyl
- agents
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 84
- 238000005187 foaming Methods 0.000 title claims abstract description 12
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 27
- 210000004761 Scalp Anatomy 0.000 claims abstract description 11
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 10
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 6
- -1 deoxyethasone Chemical compound 0.000 claims description 44
- 229920000642 polymer Polymers 0.000 claims description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- 125000002091 cationic group Chemical group 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- 239000011780 sodium chloride Substances 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000003921 oil Substances 0.000 claims description 10
- 239000006260 foam Substances 0.000 claims description 9
- 229920000768 polyamine Polymers 0.000 claims description 9
- 150000001298 alcohols Chemical class 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 235000010980 cellulose Nutrition 0.000 claims description 8
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 7
- 229940064701 Corticosteroid nasal preparations for topical use Drugs 0.000 claims description 7
- 229960001334 Corticosteroids Drugs 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 7
- 239000003246 corticosteroid Substances 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 229940083878 topical for treatment of hemorrhoids and anal fissures Corticosteroids Drugs 0.000 claims description 7
- 240000007170 Cocos nucifera Species 0.000 claims description 6
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 6
- 150000007513 acids Chemical class 0.000 claims description 6
- 229960002916 adapalene Drugs 0.000 claims description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 6
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 claims description 5
- 150000002148 esters Chemical class 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 239000005711 Benzoic acid Substances 0.000 claims description 4
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 4
- 229960002842 clobetasol Drugs 0.000 claims description 4
- FCSHDIVRCWTZOX-DVTGEIKXSA-N clobetasol Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O FCSHDIVRCWTZOX-DVTGEIKXSA-N 0.000 claims description 4
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 229920001296 polysiloxane Polymers 0.000 claims description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims description 3
- SNHRLVCMMWUAJD-SUYDQAKGSA-N Betamethasone 17-valerate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O SNHRLVCMMWUAJD-SUYDQAKGSA-N 0.000 claims description 2
- 229960004311 Betamethasone valerate Drugs 0.000 claims description 2
- 229960004436 Budesonide Drugs 0.000 claims description 2
- VOVIALXJUBGFJZ-VXKMTNQYSA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3O[C@@H](CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-VXKMTNQYSA-N 0.000 claims description 2
- 229940106189 Ceramides Drugs 0.000 claims description 2
- DJHJJVWPFGHIPH-OODMECLYSA-N Chitin Chemical class O[C@@H]1C(NC(=O)C)[C@H](O)OC(CO)[C@H]1COC[C@H]1C(NC(C)=O)[C@@H](O)[C@H](COC[C@H]2C([C@@H](O)[C@H](O)C(CO)O2)NC(C)=O)C(CO)O1 DJHJJVWPFGHIPH-OODMECLYSA-N 0.000 claims description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N Cortisol Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 claims description 2
- WBGKWQHBNHJJPZ-LECWWXJVSA-N Desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 claims description 2
- 229960003957 Dexamethasone Drugs 0.000 claims description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N Dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 2
- HQMNCQVAMBCHCO-DJRRULDNSA-N Etretinate Chemical compound CCOC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C=C(OC)C(C)=C1C HQMNCQVAMBCHCO-DJRRULDNSA-N 0.000 claims description 2
- GAKMQHDJQHZUTJ-ULHLPKEOSA-N Fluocortolone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)CO)[C@@]2(C)C[C@@H]1O GAKMQHDJQHZUTJ-ULHLPKEOSA-N 0.000 claims description 2
- 229960003973 Fluocortolone Drugs 0.000 claims description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 2
- BMCQMVFGOVHVNG-TUFAYURCSA-N Hydrocortisone 17-butyrate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCC)[C@@]1(C)C[C@@H]2O BMCQMVFGOVHVNG-TUFAYURCSA-N 0.000 claims description 2
- 229920001083 Polybutene Polymers 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- 229940029983 VITAMINS Drugs 0.000 claims description 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000002877 alkyl aryl group Chemical group 0.000 claims description 2
- 150000001783 ceramides Chemical class 0.000 claims description 2
- 230000003750 conditioning Effects 0.000 claims description 2
- FZCHYNWYXKICIO-FZNHGJLXSA-N cortisol 17-valerate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CCCC)[C@@]1(C)C[C@@H]2O FZCHYNWYXKICIO-FZNHGJLXSA-N 0.000 claims description 2
- 229960003662 desonide Drugs 0.000 claims description 2
- 239000000975 dye Substances 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 229960002199 etretinate Drugs 0.000 claims description 2
- 150000002194 fatty esters Chemical class 0.000 claims description 2
- 229950009938 flumetasone pivalate Drugs 0.000 claims description 2
- JWRMHDSINXPDHB-OJAGFMMFSA-N flumethasone pivalate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)COC(=O)C(C)(C)C)(O)[C@@]2(C)C[C@@H]1O JWRMHDSINXPDHB-OJAGFMMFSA-N 0.000 claims description 2
- 125000005456 glyceride group Chemical group 0.000 claims description 2
- 229960000890 hydrocortisone Drugs 0.000 claims description 2
- 229960001524 hydrocortisone butyrate Drugs 0.000 claims description 2
- 229960000631 hydrocortisone valerate Drugs 0.000 claims description 2
- 239000003607 modifier Substances 0.000 claims description 2
- 230000003020 moisturizing Effects 0.000 claims description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M palmitate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 claims description 2
- 235000011837 pasties Nutrition 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 229920000570 polyether Polymers 0.000 claims description 2
- 230000002335 preservative Effects 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 229920005989 resin Polymers 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims description 2
- 229960003471 retinol Drugs 0.000 claims description 2
- 239000003352 sequestering agent Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 230000000475 sunscreen Effects 0.000 claims description 2
- 239000000516 sunscreening agent Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 229930003231 vitamins Natural products 0.000 claims description 2
- 239000001993 wax Substances 0.000 claims description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 2
- 239000011701 zinc Substances 0.000 claims description 2
- 229910052725 zinc Inorganic materials 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N Stearic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 2
- XXJWXESWEXIICW-UHFFFAOYSA-N 2-(2-Ethoxyethoxy)ethanol Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims 1
- 229940022663 Acetate Drugs 0.000 claims 1
- FJXOGVLKCZQRDN-PHCHRAKRSA-N Alclometasone Chemical compound C([C@H]1Cl)C2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O FJXOGVLKCZQRDN-PHCHRAKRSA-N 0.000 claims 1
- 240000002840 Allium cepa Species 0.000 claims 1
- 229960003099 Amcinonide Drugs 0.000 claims 1
- ILKJAFIWWBXGDU-MOGDOJJUSA-N Amcinonide Chemical compound O([C@@]1([C@H](O2)C[C@@H]3[C@@]1(C[C@H](O)[C@]1(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]13)C)C(=O)COC(=O)C)C12CCCC1 ILKJAFIWWBXGDU-MOGDOJJUSA-N 0.000 claims 1
- CIWBQSYVNNPZIQ-XYWKZLDCSA-N Betamethasone dipropionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CIWBQSYVNNPZIQ-XYWKZLDCSA-N 0.000 claims 1
- 229960003721 Fluclorolone acetonide Drugs 0.000 claims 1
- NJNWEGFJCGYWQT-VSXGLTOVSA-N Fluclorolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(Cl)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1Cl NJNWEGFJCGYWQT-VSXGLTOVSA-N 0.000 claims 1
- UUOUOERPONYGOS-CLCRDYEYSA-N Fluocinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3C[C@H](F)C2=C1 UUOUOERPONYGOS-CLCRDYEYSA-N 0.000 claims 1
- WJOHZNCJWYWUJD-IUGZLZTKSA-N Fluocinonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)COC(=O)C)[C@@]2(C)C[C@@H]1O WJOHZNCJWYWUJD-IUGZLZTKSA-N 0.000 claims 1
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 claims 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims 1
- 229960005280 Isotretinoin Drugs 0.000 claims 1
- VHRSUDSXCMQTMA-PJHHCJLFSA-N Methylprednisolone Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)CO)CC[C@H]21 VHRSUDSXCMQTMA-PJHHCJLFSA-N 0.000 claims 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N Mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 claims 1
- 241000001463 Niaceae Species 0.000 claims 1
- 239000004698 Polyethylene (PE) Substances 0.000 claims 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N Prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 claims 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N Retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- SOQJPQZCPBDOMF-YCUXZELOSA-N [(8S,9R,10S,11S,13S,14S,16S,17R)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] benzoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(F)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@@H]1C)C(=O)CO)C(=O)C1=CC=CC=C1 SOQJPQZCPBDOMF-YCUXZELOSA-N 0.000 claims 1
- 229960000552 alclometasone Drugs 0.000 claims 1
- 150000008051 alkyl sulfates Chemical class 0.000 claims 1
- 229960000870 betamethasone benzoate Drugs 0.000 claims 1
- 229960001102 betamethasone dipropionate Drugs 0.000 claims 1
- XWTIDFOGTCVGQB-FHIVUSPVSA-N butyl 2-[(6S,8S,9S,10R,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetate Chemical group C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2C[C@@H](C)[C@H](C(=O)C(=O)OCCCC)[C@@]2(C)C[C@@H]1O XWTIDFOGTCVGQB-FHIVUSPVSA-N 0.000 claims 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 claims 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims 1
- 229940042902 flumethasone pivalate Drugs 0.000 claims 1
- 229940043075 fluocinolone Drugs 0.000 claims 1
- 229960000785 fluocinonide Drugs 0.000 claims 1
- 229950008509 fluocortin butyl Drugs 0.000 claims 1
- 229960002383 halcinonide Drugs 0.000 claims 1
- 229960001067 hydrocortisone acetate Drugs 0.000 claims 1
- 229960004584 methylprednisolone Drugs 0.000 claims 1
- 229960001293 methylprednisolone acetate Drugs 0.000 claims 1
- PLBHSZGDDKCEHR-LFYFAGGJSA-N methylprednisolone acetate Chemical compound C([C@@]12C)=CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C)[C@@](O)(C(=O)COC(C)=O)CC[C@H]21 PLBHSZGDDKCEHR-LFYFAGGJSA-N 0.000 claims 1
- 229960002744 mometasone furoate Drugs 0.000 claims 1
- 235000002732 oignon Nutrition 0.000 claims 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- 229920000573 polyethylene Polymers 0.000 claims 1
- 229960005205 prednisolone Drugs 0.000 claims 1
- 235000020944 retinol Nutrition 0.000 claims 1
- 239000011607 retinol Substances 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 claims 1
- 150000003512 tertiary amines Chemical class 0.000 claims 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-M valerate Chemical compound CCCCC([O-])=O NQPDZGIKBAWPEJ-UHFFFAOYSA-M 0.000 claims 1
- 229940070710 valerate Drugs 0.000 claims 1
- SJZRECIVHVDYJC-UHFFFAOYSA-N γ-Hydroxybutyric acid Chemical compound OCCCC(O)=O SJZRECIVHVDYJC-UHFFFAOYSA-N 0.000 claims 1
- 230000000149 penetrating Effects 0.000 abstract 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 18
- 239000002453 shampoo Substances 0.000 description 16
- 239000000047 product Substances 0.000 description 15
- 150000003254 radicals Chemical class 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 241000282372 Panthera onca Species 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 108010009736 Protein Hydrolysates Proteins 0.000 description 8
- 229920001577 copolymer Polymers 0.000 description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 6
- 150000001450 anions Chemical class 0.000 description 6
- 239000001913 cellulose Substances 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 6
- 239000000194 fatty acid Substances 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- IAYPIBMASNFSPL-UHFFFAOYSA-N oxane Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 229960000686 Benzalkonium Chloride Drugs 0.000 description 5
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 5
- 229920001519 homopolymer Polymers 0.000 description 5
- GETQZCLCWQTVFV-UHFFFAOYSA-O trimethylammonium Chemical group C[NH+](C)C GETQZCLCWQTVFV-UHFFFAOYSA-O 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N Citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 210000003491 Skin Anatomy 0.000 description 4
- 241000209140 Triticum Species 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 229960005188 collagen Drugs 0.000 description 4
- SEKVTWKYOIVNGT-UHFFFAOYSA-L disodium;dodecan-1-ol;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCO SEKVTWKYOIVNGT-UHFFFAOYSA-L 0.000 description 4
- 235000021317 phosphate Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 239000003531 protein hydrolysate Substances 0.000 description 4
- 125000001453 quaternary ammonium group Chemical group 0.000 description 4
- 235000021307 wheat Nutrition 0.000 description 4
- 229960004703 Clobetasol Propionate Drugs 0.000 description 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N Methyl radical Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K [O-]P([O-])([O-])=O Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 150000001408 amides Chemical class 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 201000004681 psoriasis Diseases 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- 239000011778 trisodium citrate Substances 0.000 description 3
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K 2qpq Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- CWSZBVAUYPTXTG-UHFFFAOYSA-N 5-[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxymethyl]-3,4-dihydroxy-5-[4-hydroxy-3-(2-hydroxyethoxy)-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)-2-methyloxane-3,4-diol Chemical group O1C(CO)C(OC)C(O)C(O)C1OCC1C(OC2C(C(O)C(OC)C(CO)O2)OCCO)C(O)C(O)C(OC2C(OC(C)C(O)C2O)CO)O1 CWSZBVAUYPTXTG-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N Adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229940045714 Alkyl sulfonate alkylating agents Drugs 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 240000005497 Cyamopsis tetragonoloba Species 0.000 description 2
- 229940031574 HYDROXYMETHYL CELLULOSE Drugs 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000002535 acidifier Substances 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 150000008052 alkyl sulfonates Chemical class 0.000 description 2
- 125000004429 atoms Chemical group 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 2
- 229960003920 cocaine Drugs 0.000 description 2
- ZPUCINDJVBIVPJ-BARDWOONSA-N cocaine Natural products O([C@@H]1C[C@H]2CC[C@H](N2C)[C@@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-BARDWOONSA-N 0.000 description 2
- 230000000875 corresponding Effects 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 150000002191 fatty alcohols Chemical class 0.000 description 2
- 150000002193 fatty amides Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 2
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000002829 nitrogen Chemical group 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229920001281 polyalkylene Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 229940097319 quaternium-22 Drugs 0.000 description 2
- 150000003335 secondary amines Chemical group 0.000 description 2
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4E)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical compound O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 description 1
- BJPNXSAZVVZIOG-UHFFFAOYSA-N 1-hydroxyethyl 2-hydroxybenzoate Chemical compound CC(O)OC(=O)C1=CC=CC=C1O BJPNXSAZVVZIOG-UHFFFAOYSA-N 0.000 description 1
- VHLVYPQCBYDNKM-UHFFFAOYSA-N 18,18-dimethylnonadecylazanium;chloride Chemical group [Cl-].CC(C)(C)CCCCCCCCCCCCCCCCC[NH3+] VHLVYPQCBYDNKM-UHFFFAOYSA-N 0.000 description 1
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-Furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- GQWWGRUJOCIUKI-UHFFFAOYSA-N 2-[3-(2-methyl-1-oxopyrrolo[1,2-a]pyrazin-3-yl)propyl]guanidine Chemical group O=C1N(C)C(CCCN=C(N)N)=CN2C=CC=C21 GQWWGRUJOCIUKI-UHFFFAOYSA-N 0.000 description 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical compound [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229940061720 Alpha Hydroxy Acids Drugs 0.000 description 1
- HTIQEAQVCYTUBX-UHFFFAOYSA-N Amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 description 1
- 229940025660 Anthralin Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N Betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O CC[NH+](CC)CC Chemical group CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 210000001736 Capillaries Anatomy 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N Clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229940108066 Coal Tar Drugs 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- RPNUMPOLZDHAAY-UHFFFAOYSA-N DETA Chemical compound NCCNCCN RPNUMPOLZDHAAY-UHFFFAOYSA-N 0.000 description 1
- NUZWLKWWNNJHPT-UHFFFAOYSA-N Dithranol Chemical compound C1C2=CC=CC(O)=C2C(=O)C2=C1C=CC=C2O NUZWLKWWNNJHPT-UHFFFAOYSA-N 0.000 description 1
- 208000005679 Eczema Diseases 0.000 description 1
- 210000002615 Epidermis Anatomy 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N Ethyl radical Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- HYBBIBNJHNGZAN-UHFFFAOYSA-N Furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 206010019049 Hair texture abnormal Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 206010020648 Hyperkeratosis Diseases 0.000 description 1
- 241001527806 Iti Species 0.000 description 1
- 244000232488 Jessenia polycarpa Species 0.000 description 1
- 235000002407 Jessenia polycarpa Nutrition 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- 206010025135 Lupus erythematosus Diseases 0.000 description 1
- 206010025482 Malaise Diseases 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N Methacrylamide Chemical group CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- 229920003102 Methocel™ E4M Polymers 0.000 description 1
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N N,N'-Methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinylpyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- XAPRFLSJBSXESP-UHFFFAOYSA-N Oxycinchophen Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=C(O)C=1C1=CC=CC=C1 XAPRFLSJBSXESP-UHFFFAOYSA-N 0.000 description 1
- 206010033898 Parapsoriasis Diseases 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 241000183024 Populus tremula Species 0.000 description 1
- 229920002305 Schizophyllan Polymers 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- JNYAEWCLZODPBN-CTQIIAAMSA-N Sorbitan Chemical compound OCC(O)C1OCC(O)[C@@H]1O JNYAEWCLZODPBN-CTQIIAAMSA-N 0.000 description 1
- 229940001941 Soy Proteins Drugs 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- 229960001727 Tretinoin Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N Triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K Trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- DRTQHJPVMGBUCF-UCVXFZOQSA-N Uridine Natural products O[C@H]1[C@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UCVXFZOQSA-N 0.000 description 1
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 1
- 229940045145 Uridine Drugs 0.000 description 1
- 229920001567 Vinyl ester Polymers 0.000 description 1
- 229940045997 Vitamin A Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000003926 acrylamides Chemical group 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- DJHCCTTVDRAMEH-DUUJBDRPSA-N alclometasone dipropionate Chemical compound C([C@H]1Cl)C2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O DJHCCTTVDRAMEH-DUUJBDRPSA-N 0.000 description 1
- 229960004229 alclometasone dipropionate Drugs 0.000 description 1
- 235000015107 ale Nutrition 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229960001716 benzalkonium Drugs 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-M benzoate Chemical compound [O-]C(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-M 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- CYDRXTMLKJDRQH-UHFFFAOYSA-N benzyl-dodecyl-dimethylazanium Chemical compound CCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 CYDRXTMLKJDRQH-UHFFFAOYSA-N 0.000 description 1
- WGQKYBSKWIADBV-UHFFFAOYSA-O benzylaminium Chemical group [NH3+]CC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-O 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- 230000001588 bifunctional Effects 0.000 description 1
- HSUIVCLOAAJSRE-UHFFFAOYSA-N bis(2-methoxyethyl) benzene-1,2-dicarboxylate Chemical compound COCCOC(=O)C1=CC=CC=C1C(=O)OCCOC HSUIVCLOAAJSRE-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005824 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 150000004985 diamines Chemical group 0.000 description 1
- 229960002124 diflorasone diacetate Drugs 0.000 description 1
- BOBLHFUVNSFZPJ-JOYXJVLSSA-N diflorasone diacetate Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)COC(C)=O)(OC(C)=O)[C@@]2(C)C[C@@H]1O BOBLHFUVNSFZPJ-JOYXJVLSSA-N 0.000 description 1
- 229960002311 dithranol Drugs 0.000 description 1
- CLLKUSRBGZGQSF-UHFFFAOYSA-N dodecyl hydrogen sulfate;ethane-1,2-diol;2-(2-hydroxyethylamino)ethanol Chemical compound OCCO.OCCNCCO.CCCCCCCCCCCCOS(O)(=O)=O CLLKUSRBGZGQSF-UHFFFAOYSA-N 0.000 description 1
- 231100001003 eczema Toxicity 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002118 epoxides Chemical group 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229960004667 ethyl cellulose Drugs 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PYGSKMBEVAICCR-UHFFFAOYSA-N hexa-1,5-diene Chemical group C=CCCC=C PYGSKMBEVAICCR-UHFFFAOYSA-N 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 230000003902 lesions Effects 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atoms Chemical group N* 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002927 oxygen compounds Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-O phenylazanium Chemical group [NH3+]C1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-O 0.000 description 1
- NJRWNWYFPOFDFN-UHFFFAOYSA-L phosphonate(2-) Chemical compound [O-][P]([O-])=O NJRWNWYFPOFDFN-UHFFFAOYSA-L 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- 125000003386 piperidinyl group Chemical group 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920001888 polyacrylic acid Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 150000004291 polyenes Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001823 pruritic Effects 0.000 description 1
- 230000001185 psoriatic Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 101700022803 retm Proteins 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-M stearate Chemical class CCCCCCCCCCCCCCCCCC([O-])=O QIQXTHQIDYTFRH-UHFFFAOYSA-M 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- USFMMZYROHDWPJ-UHFFFAOYSA-N trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium Chemical compound CC(=C)C(=O)OCC[N+](C)(C)C USFMMZYROHDWPJ-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000004034 viscosity adjusting agent Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011276 wood tar Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Abstract
The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium:at least an active principle selected among corticoids and retinoids;at least an anionic surfactant;at least an amphoteric surfactant;and a pro-penetrating agent.
Description
COMPOSITION FOAM FOR HAIR CARE
DESCRIPTION OF THE INVENTION The present invention relates; foaming compositions for washing and treating the hair and / or scalp, which contains an amphoteric surfactant and a ptopepeptide / isi agent, as with the lysate process, said compositions. all the chronic diseases of the
common. This disease is observed in 1.4 to 2.9% of the population. The scalp is one of the most common sites due to psoriasis, which causes a malaise, cysts, peeling, keratosis, pruritus and may also be responsible for a reduction in capillary density. The treatments used until now resort to salicylic acid, local steroids, anthralin or coal tar or wood tar. These treatments are unpleasant, especially when applying tar and require long applications, particularly when using hair ointments. Ref: 124763 In order to improve the quality of life of the patient, without reducing the therapeutic effect of the treatment, foaming compositions containing corticosteroids have been perfected. More specifically, the time of application of these foaming compositions is reduced with respect to the
Patent BE 84515 discloses a composition containing the hydrochlorone in a solvent mixture consisting of 15 to 601 aliphatic alcohol, 15 to 601 propylene glycol and 5 to 60%, of a third solubilizing agent selected from the group consisting of hydroxy-2-ethyl salicylate, dipropiicetone and dimethyl cocobenzylamine chloride. EP 0 325 949 discloses a solution comprising at least 2.5 'of corticosteroids, of
? - ct O? or uc ex / U or uc f i 'n ri f-f £ > v-, f-? arit i m i crobi ano. However, the solvents present in these compositions tend to evaporate very rapidly. In addition, the fluidity of these compositions makes application difficult and it is usually necessary to apply these compositions by friction to allow efficient penetration of! or.? nrinrin ^ ns active, which causes greater irritation of the epidermis, or to apply these compositions and let them act for several hours, with the consequent discomfort of the patient. of the solvent, a foam containing a corosteroid, a foam-cutting agent, a propellant and a buffer was proposed in patent WO 962-376. The foam-cutting agent is composed of an aliphatic alcohol, water, a fatty alcohol and A non-ionic surfactant, however, when these foams are applied to non-ionic fibers, their resultant aesthetic appearance is not satisfactory and the scalp located under the keratin fibers can be treated insufficiently. i- - ± - J- Liild. i- u iUlI UC 1 ^ a- -? -? ¿? -? - £ -'-- Ctv ^ i j- ._ > li -i- Cl - - - 1. ^ C. »I / al / prs nt do auzus propi d es cos t ics The Applicant has now perfected a foaming composition having the enclosed properties, the compositions of the present invention, while they allow a good penetration of the active principles, they also present an improvement of the cosmetic performances of e the compositions for the treatment of skin or hair conditions, leaving the hair soft, elastic and non-greasy. In addition, these compositions are easy to rinse. The Applicant has also found that the foaming compositions of the present invention made it possible to obtain, surprisingly, a foam having improved volume and compactness characteristics compared to foam compositions for the treatment of skin conditions.
: uero rte a n r o v i f- v- T -L dzi mxLL - > v -i or S-. r.L-.iL O c QC ni aq pC / / -3 O m iti -pup, i- C-l sorpr ndent, the corpositions object of the present invention are stable in time, allowing to avoid the precipitation of the principles assets and staying
Therefore, one of the objects of the invention is constituted by a foam composition for the washing and treatment of the hair and / or of the leather fit 11. Another object of the invention is a method of washing and treating the hair and / or the scalp that applies this composition. An object of the invention is also a composition according to the invention for its use as a medicament.
An object of the invention is also the use of the compositions of the invention as a medicament and for the manufacture of a medicament intended to treat skin or skin conditions.
hair Other objects of the invention will appear with a reading of the description and the following examples. The foaming composition for washing and treating the caoello and / or the scalp is essentially characterized in that it contains, in a medium, at least: - at least one active ingredient selected from corticosteroids and retinoids, - at least one anionic surfactant, i | . ' - r \ -y? _ - "i ~ r ~ -? * R? O r-, - ^ > ciiirprciq r- 1- ittt • -ni ru-, - - tL--? C -L / ~ v In the context of the present invention, corticosteroids can be chosen from alclometasone dipropionate, ameinonide, belamethasone dipropionate, betamethasone TJ benzoate, dipropionate a or betametaeone. , betamethasone valerate, budesonide, ciobetaeol propionate, preferably clobetasol propionate, clobetasol bromide, desonide, deoxyethasone, dexamethasone, diflorasone diacetate, and flurandrenoione, fiuprednidene acetate, fluocortolone, fiuccortin butyl, f1ooc inonide, fluocmolone acetonide, fluclcrolone acetonide, flumetasone pivalate, feudiiine hydrochloride, fluol, etholone, uridine / idioid -? u? j xoun c _L d C QLU of hydrocortisone, hydrocortisone butyrate, hydrocortisone valerate, acetat or metiiprednisolone, ometasone furoate, methylpreanisolone, prednisoione, tiidi acetonide "Cinolone or between pharmaceutically acceptable mixtures of the latter. The retirhoids can be chosen from the t-trans-tonic acid also known as tretinoin or amine acid A, adapalene, isotret moine, retmcl, ie vitamin A and its derivatives, such as acetate, palmitate or propitiate of retino !, the motretmide, the etretinate, the acitretma, the t-trans retm? dtu e zinc, retmoides of third generation optenidos by the addition of cyclic groups in the polyene side chain, also called arotinoides, or synthetic retinoids or between pharmaceutically acceptable mixtures of the latter.
Among the retinoids, adapalene, 4- [7- (1-adamantii) -6-methoxyethoxy-ethyoxy-2-naphthyl-3-benzoic acid, 2-hydroxy-4- [3-oxo-3- ( 3-tert-butyl-4-methoxyphenii) -1-propynyl] benzoic acid and 4- (3, 5, 5, 8, 8, -pentamethyl-5,6,7,8-tetrahydro-2-naphthylthio) benzoic acid . The particularly preferred active ingredient among corticosteroids is ciobetasoi-17-propionate. The active principle can be used in proportions of 0.001 to 51, preferably between 0.01 to 0.3% and more preferably between 0.05 and 0.1% by weight
In the framework of the present invention, the nature of the anionic surfactants does not have the truly critical character. Thus, as an example of anionic or ilishable surfactants, alone or in combination, salts may be mentioned
[in particular alkali salts, specifically sodium, ammonium salts, amine salts, salts of ami or alcohols or magnesium salts) of the following p -t- ^ c- '] O ^ p 1 A-ii i 1 in 1 f , q rr > or]! ~! c *,] m ""! P t "p v-? I: 1 f q A α alkylates idoetersulfates, alkylaryl polyether sulfates, monoglyceride sulphates, alkylsulfonates,
3i: 1 t? Fatos, aiquilamidosulfonates, the
alkylsulfonates, a-silyphine-suifonates, paraffin-suifonates, alkylsulfosuccinates, aicylethylsulfosuccinates, alkylamidosuiphosuccinates, aminosulfosuccinamates, alkylisuiphathates, alkyl ether phosphates, acylsarcosylates, acyl isethionates and N-acylaurates, containing the alkyl or acyl radical of ef - ^ if? pnr a r, mr? i? o crf- >;? and ^ v ~ cs ^ c > ~ e2¡- -t ~ 2? -rn ec y ~ > l- e ^ H ^ ^ 1 0; * or? W c rl £ / - "a > ~ ^? - > io rt? a H i C * ~ *" i P ^ 1 a r í] preferably a phenyl or benzyl group. Among the also useful ammonium surfactants, the salts of
ricinoleic, oalmitic, stearic, the copra oil or hydrogenated copra oil acids, the acyl-iactylates whose acyl radical comprises 8 to 20 carbon atoms.
A 3 rh? T om -i Ar ^ ^ i i * - > , -Ñ '-i r- > nr i l i 73 VCD f pri? i? I added a few anionics, such as alkylcarboxylic acids, as well as polyoxyalkylenated polyoxycarboxylic acid carboxylic acids, carboxylic polyoxyalkylenated carboxylic acids, carboxylic acidic carboxylic acids (CG_C2) and its salts, in particular those having from 2 to 50 ethylene oxide groups, and mixtures thereof.
Among the ammonium surfactants, ^ v -r? pe pr? ~?
a l pn ^ c * p tt? p 7 p 1 a More particularly, ST prefers to use the
I sp - T l c.t-civ-? N l -r -a t- river O ^ "i ^ f a? OT" i P? ori f, 1 pl marketed under the name "Texapon N70" '", the sodium lauryl ether suface, especially marketed under the name" Sipon AOS 225 UP * ", and the sodium riisuitate, especially the surfactant. Anionic agents can be used in proportions comprised between 0.05 and 501, preferably between I and 301 and more preferably of Active Material iM.A.) by weight with respect to
1 ac. DO; : to L; / "•» surfactants at n f o t o r, s "I 1 T"? I 7? Character has: r? T? Cc e or "arc of the present invention, can be in
CSOCí i I r ~ i c v-T a n r ^ ^ e -i Tr »T n, a < c * ¿-z 1u 1naarias or tertiary
0 straight or branched chain with 8 to 22 carbon atoms and with at least one water-solubilizing anionic group (for example carboxylate, sulfonate, sulfate, phosphate or phosphonate); there may also be mentioned the alkyl (CB-Ci?) betaines, the sulfobetams, the alkyl (CS-C-c) to idoalkyl (d-Ce) betaines and the alkyl (CD-C) amidoaikyl Ci-Cß) sulfobetaines. Among the derivatives of amines, there may be mentioned the products marketed under the names MIRANOL, such as those described in patents US-2 528 378 and US-2 781 354 and of structures:
R2-CONHCH2-CH -N (R3) (RJ (CH COO ~)
wherein: R_ designates an alkyl radical derived from an acid R_-COOH present in the hydrogenated copra oil, a heptyl, nonyl or undecyl radical, R "designates a betahydroxyethyl group and R4 a group
where 1: B represents -CH2CH_0X ', C represents - (CH?) z-Y', with z =
1 or 2, X denotes the group -CK_CH_-COOH or an atom of il ^ v-Á nn Y 'designates -COOH or the alkyl radical -CH_-CH0H-S0jH RG designates an alkyl radical of a fatty acid Ro-COOH in the copra oil or in the hydrolyzed linseed oil, an alkyl radical, especially in CT, Cy, Cl t or Cl! (an alkyl radical in C- and its iso form, an unsaturated C ^ radical.
These compounds are classified in e. ' dictionary; A, / ma 1 QQ tí,) ai (the designations Disodio Cocoanfodiacetato, Disodio T) i hate pn i 1 T) 1iS! do not
In the case of other surfactants, cocolbetaines are particularly preferred, and, in particular, cocaine, especially commercialized cocaine. These amphoteric reactants can be
UT i i 1 7 a *.? to nv? The values are between 0.01 and 301, preferably between 0.5 and 20%, preferably between I and 151 of A. by weight with respect to the total weight of the product.
month in M.A. of the t eps 1 o a c1 o = ap3 eos and of the amphoteric surfactants
^ C t-r-O v? N? TTirin t-? i "-1- v ~ 0 and most preferably; .c 2 and 1. E C ire" 11- - ^ ~ "" i *? "Í c ** ^ ^ f T" Ti t ~ mi > r ~! »~ Rn? T ~ p f 3 fí 1 i f" l e p e r t c e n of the active ingredients, is
Pvo f? or -not -substanting of the active compound present in the compound. Particularly, it is chosen from the volatile alcohols in C? -C4 / such as ethanol, isopropanol, between the polyhydric alcohols such as propiiengiol and between the glycol ethers as the ethoxydigiic'oi. The preferred propenetrating agent in the context of the present invention is ethanol. Propenetrating agents can be used in concentrations between 0.1 and
% and preferably comprised between 5 and 10% by weight with respect to the total weight of the composition. The ratio between the proportion in M.A. of the anionic surfactants and the proportion of the agents p open tr nt s is preferably comprised between 0.1 and 10 and more preferably between 0.5 and 5 and even more
, as r > > I decided to make an invention by improving its improved properties by adding, for example, cationic polymers, acrylic polymers, cellulose derivatives whether or not they are processed. The cationic polymers which can be used according to the present invention can be selected from among themselves and from > s in themselves to improve
detergent compositions, namely those described in patent application EP-A-0 337 354 and French patent applications FR-A-2 270 846, 2 383 660, 2 598 611, 2 470 596 and 2 519 863. Still more generally, in the sense of the present invention, the term "cationic polymer" refers to any polymer containing groups R H? Pi rn? Pn QrUDn? rsH? n i. { -ns. Preferred cationic polymers are chosen from those containing motifs with primary, secondary, tertiary and / or quaternary amine groups which may either be part of the polymeric chain or be contained in a ral directly linked thereto. The cationic polymers used generally have a molecular weight in the number comprised xi c: ^ and > . x to u? iaQ aiLt ii LC and μx cx l cilLci cli The range between 00 ~ and 3.10 aproximadamente approximately. Among the cationic polymers, quaternized proteins (or protein hydrolysates) and polyamines of the polyamine, polyaminoamide and quaternary phenylammonium type can be mentioned more particularly. These are known products. Proteins or hydrolysates of quaternized proteins are in particular modified polypeptides which contain at the end of the chain or are transplanted thereon, quaternary ammonium groups. Their molecular mass can vary, for example, from 1,500 to 10,000 and in particular from 2,000 to 5,000 approximately. Among these compounds, mention may be made in particular of: - collagen hydrolysates with triethylammonium groups such as the products sold under the name "Quat-Pro E" by the company MAYBROOK and designated in the CTFA dictionary "Triethonium Hydrolyzed Collagen Ethosulfate"; - Collagen hydrolysates with trielammonium chloride and trimethylstearylammonium chloride groups, sold under the name "UAT-Pro S" by the Maybrook Company and designated in the CTFA dictionary. "Steartrimonium Hydrolyzed Coil agen"; - hydrolysates of animal proteins that have r i met i 1 benzylammonium groups or such as the products sold under the maize "Crotem BTA" by the CROD / v Company and designated in the CTFA dictionary
- the protein hydrolysates having in the polypeptide chain quaternary ammonium groups with at least one alkyl radical having 1 to 18 carbon atoms. Among these protein hydrolysates, they may include, among others: ^ roquat L "whose quaternary ammonium groups .Iqurlo in Cu - the" fi? Frnn? R / - > ri "t -n -i T te" -r -? ~ p ^ - "" and x- ^. ^^^ ".U" .. xv,, "- the" Croquat S "whose quaternary ammonium groups comprise at least one alkyl group having 1 to 18 carbon atoms. These different products are sold by the
: as? as or h: iroiizaaos cuate: .zaaos so: ej e p. What do you think of the rormuia?
in which .x.β is an anion, na, an aci.a, or org, ni.co or mineral, A designates a protein residue derived from collagen protein hydrolysates, R5 designates a lipophilic group with up to 30 carbon atoms, RD represents an alkylene group with 1 to 6 carbon atoms
: arbono Mention may be made, for example, of the products sold by the Inolex Company under the name "Lexein QX 3000", designated in the CTFA dictionary "Cocotr imonium Collagent Hydrolysate".
The prroo can also be cited !! rt a •? quaternized ales such as wheat, corn or soy proteins: as quaternized wheat proteins, those commercialized by the Croda Company can be mentioned: and QQ? 1M "in the CTFA dictionary" Cocodimonium Hydrolysed heat protein ", "Hydrotriticum QL" designated in the CTFA dictionary "Laurdimonium hydrolysed wheat protein" or also "Hydrotriticum QS", designated in the CTFA dictionary "Steardimonium hydrolysed wheat protein." The polymers of the polyamine, polyamidoamide, polyamonic quaternary type, usable in accordance with the present invention, which can be mentioned in particular, are those described in the narpnrp? -Fv-rir-OQ cr n ° AM A "í / 1 fi A 9 * - \? QQ T "i" T P *
metacriiate diaqualamoaquilil quaternized or not, such as the products sold under the denomination? ^ uiw C v_i S, as for example Gafquat
734, 755 or HS100 or the product called
"Copolymer 937". These polymers are described in detail in French patents 2 077 143 and 2 393 573. (2) The cellulose ether derivatives that quaternary ammonium described in the French patent 1 492 597 and in particular the polymers marketed under the names "JR" (JR 400, JR 125, JR 30M) or "LR" (LR 400, LR 30M) by the Union Carbide Corporation. These polymers are also defined in the CTFA dictionary as ammonium
with an epoxide substituted by a trimethylammonium group. (3) Cationic cellulose derivatives such as cellulose copolymers or cellulose derivatives transplanted with a quaternary ammonium hydrosolubic monomer and described in particular in US Pat. No. 4,131,576, such as hydroxyalkyl celluloses, such as hydroxymethyl-, Hydroxyethyl- or hydroxypropyl cellulose transplanted
ir id idial i l mo ni o. Products coded to the markets that respond to this goal. more particularly what products
L 200"and" Celq- -nt H 100"for the National Society
Qt a v ~ t ~ - V > (4) The cationic elisaccharides described more particularly in US Pat. Nos. 3 589 57I and 4 031 30 ~ i? = = > i like guar gums containing trialkyl onium cationic. For example, guar gums modified by a salt (for example chloride) of 2,3-e? Oxypropyl trimethylammonium are used. Such products are marketed, in particular, under the trade names of JxAGUAR C13 S,
JAGUAR C 15, JAGUAR C 17 or JAGUAR C162 by society i-i ii, Y H j_? • (5) polymers formed by piperazil and by divalent radicals to qui leno or hixydiaxyalkylene with straight or branched chains, optionally interrupted by oxygen compounds,
particular are given to the patches (6) water-soluble polyamphenamides prepared in particular by polycondensation of an ac compound or a polyamine; these poly minoamides
thousand uci x v auu J ii d UJ.a? Aila UA Iiaiuii uíliia / il -LO aceti inio, a bis-haio cildiamina, a bis-halogenurc of alkyl or also by an oiigomer resulting from the reaction of a bi-functional compound reactive towards a bishalohydrin, of a bis-acetidinium , of a bis-haioacylidiamine, of o - a | A * / a? ? ae ae one or i T q l r? i a rl s n ^ "í P ^? v 'H ¡O H p 1 1 Ti H? ~ í t¡r; fl H Ì. - unsaturated, using the crosslinking agent in proportions ranging from 0.025 to 0.35 mol per amine group
alkylated or, if they contain one or more tertiary, quaternized amines. Such polymers are described in particular in the patents
French 2,252,840 and 2,366,508; (7) the polyaminoamide derivatives resulting from the condensation of polyalkoylenes polyamines with polycarboxylic acids followed by an alkylation by bifunctional agents, for example, the adipic acid-diacmydiahydroxyalkyldiallylenetriamine polymers in which the alkyl radical comprises from 1 to 4 carbon atoms.
• A A -i 1 > 1-? 1 propilc. These polymers are described
specifically in French patent 1,583,363. Among these derivatives, mention may be made more particularly of the polymers adipic acid / dimethylamine hydroxypropyl / diethylene triamine sold under the name "Cartaretine F, F4 or F8"
-? by the Sandez society.
(8) polymers obtained by reacting a polyalkylene polyamine with two primary amine groups and at least one secondary amine group with a dicarboxylic acid chosen from diglicic acid and saturated aliphatic dicarboxylic acids containing from 3 to 8 carbon atoms. The molar ratio between the polyalkylene polyol and the dicarboxylic acid is W? 1mHr /. LnUUí UAU or Cn XX l I L-Q t. n, p • • _iX _y i X-, Ti •. l X, "X], U - = * rn -lJ L ^ Almlii, ai ti a L i ui r x] Cl P i l O h i í Tl
? -i nm p TQ 1 i A m an m 1 cj v- JP 1 secondary amine group of the polyaminoamide between 0.5: • n i an: spe < . ricamei e Patents
These types are commercialized in the I Ai-iCi Ti? A 'Hercosett for the name of the company Hercules in the case of eopo x ime r o ae acide'
or dimethyl diallyl ammonia such as homopoiimers containing a major component of the chain motifs corresponding to formulas (VI) or (VI): designate an alkyl group with 1 to 22 carbon atoms, a hydroxyalkyl group in which the alkyl group preferably contains 1 to 5 carbon atoms, a lower amidoalkyl group or R10 and R1X may designate together with the nitrogen atom to which they correspond, heterocyclic groups such as piperidinyl or morpholinyl; . ' Yü is an anion such as bromide, chloride, acetate, borate, citrate, ta-rtrate, bisulfate, bisulfite, sulfate, phosphate. These polymers are specifically described in the French patent 2,080,759 and its certificate of addition 2,190,406. Among the polymers defined above, mention may be made more particularly of the homopolymer of dimethyldiallylammonium chloride sold under the name "Merquat 100" by the company Merck. (10) the quaternary diammonium polymer with recurring motifs that correspond to the formula:
formula (VII) in which: Ri3 'Ri4' Ri5 and Ri6 'identical or different, represent aliphatic, alicyclic or arylaliphatic radicals with 1 to 20 carbon atoms or hydroxyalkylaiphatic radicals
formulas in which k and t are equal to u or i, sienao the sum k + t equal to 1; R 12 denotes a hydrogen atom or a methyl radical; Rio Y Rn '- independently of each other, designate an alkyl group with 1 to 22 carbon atoms, a hydroxyalkyl group in which the alkyl group preferably contains 1 to 5 carbon atoms, a lower amidoalkyl group or Rio and R_ can designate with the nitrogen atom to which they correspond, heterocyclic groups. . . , -r? such as ^ i ^ and idiniio or mo foiinilo i is an anion such as bromide, chloride, acetate, borate, citrate, tartrate, bisulfate, bisulfite, sulfate, phosphate. These polymers are specifically described in the French patent 2,080,759 and in their certificate of d Q X C 1 1i ¿. X V. * - * O. Among others, the dimethyl urea diammonium homopolymer sold under the name "Mersuat 100" DOG by Merck, has been among the most important. - > - >
) pl .i erc ae di.amo io 'v at er. to. n Recurring reasons that respond to the n T-rm i I p
XUXllLUXI ÍUT T \ V x j. which: Rl3, Ru, RtJ and Rio, identical or different, represent aliphatic, alicyclic or arylaliphatic radicals with 1 to 20 carbon atom or radicals h. y y i a 1 11 -í 1 a l i i t i i n f i p
Nitrogen atoms to which the occu tionally correspond a second time? "i -rp v-pt-vf- p rl well K ^, K. ,, Rl3 and Rif,: a? alkyl in Ci-Co linear ox TA Xt- xt L -.- HAl / A o_)" I 1 c - a nitrile, ester, acyl, amide or - 7 0-P-D or -CQ-NH-R --- p group where P.-7 is a
ü :: aieG or branched, saturated m = aturated, / oue may contain, bound or azurri groups sulfoxi or, sulfo a, U -: 11 i 1- n r n amide or ester and X, - < = > designates an anion derived from an atom nitrogen atoms to which a piperazinic cycle corresponds, in addition if Ax designates a 1 i: aaole, unsaturated saturated or unsaturated radical, it may designate a group (CH2) - C0-D-OC- ( CH2) in which D designates: a) a giicol residue of the formula: -0-ZO-, wherein Z denotes a linear or branched hydrocarbon radical or a group which corresponds to one of the following formulas:
-ni -GK -Í -? t? • 0] -CH2-CH (CH-) - where x and y designate an integer from 1 to 4, which represents a defined and unique polymerization degree c any number from 1 to 4 representing a degree of
b) a bis-secondary diamine residue such as a piperazine derivative;
c) an amino-bis-primary radical residue: -NH-Y-NH-, where Y denotes a linear or branched hydrocarbon radical or the bivalent radical -CH.-CH ..- -F > ? rm l. It is preferable that X is a tai anion such as the cyano or bromide, these polymers have a molecular mass in number generally between 1,000 and 10,000.00 Polymers of this type are specifically described in US Pat. French patents 2,320,330, 2,270,646, 2,316,271, 2,336,434 and 2,413,907 and US Patents 2,273,780, 2,375,853, 2,388,614, 2,454,547, 3,206,462, 2,261,002, 2,271,378, 3,874,870, 4,001,432, 3,929,990, 3,966,904, 4,005,193, 4 p ~ IÍI ~ 7 u ~ f, ~ ~ p ~ -r.-3 non (1-. Polymers of quaternary polygons Constituted by reasons of formula (VIII):
TO-
in which:
Rí, Ki5 R2? and R2i identical or different, represent a hydrogen atom or a methyl radical, pr i i n n? Tii 1 n R -? i oh i 1 n R-HÍTr XÍD ODÍ l? O -
CH2CH2 (OCH2CH2) ¡.OH, where p is equal to 0 or to an integer between 1 and 6, with the proviso that R1, Ri i, R.AA and RA, do not simultaneously represent an
without ? r * cs c tß es, are whole numbers
q is equal to 0 or to an integer comprised between tre 1 and 3, V i. r s_- > c \ _s f? > a nrn »T i n 1 n < * (£.? / A designates a radical of a dihalide or preferably represents -CH2CH_-0-CH-CH2-) is found in the patent application EP-A-122 324. For example, there may be mentioned among these ios. products "Mirapol A 15", "irapol AD1", "Mirapol AZI" and "Mirapol 175" sold by the company Miranol. (12) homopolymers or copolymers derived from acrylic acid mclicacrylic and containing molds:
R, 'il 9 »CH2-C CH2 c CH2" C 1! O = c O =! = C O = C I or i NH O
I V r 1- R 2 $ ^ 4 M. R »'N + - Ri4 1 R2S ** 7 R 23 y / o
in which the groups R_: independently designate H or CH, groups A, independently designate a linear or branched aleoyl group of 1 to 6 carbon atoms or a hydroxyalkoyl group of 1 to 4 carbon atoms, the groups R_, R_ , R_5, identical or different, independently designate an alkoyl group of 1 to 18 carbon atoms or a benzyl radical, the groups R and R_- represent an atom a n í p? to ? X aesi na Ü? ?,, ejer ejer ejer por por por por por por por por por Ap Ap Ap Ap Ap Ap Ap Ap Ap Ap Ap Ap Ap Ap. The comonomer (s) that can be used in the T-p qi-nr-? OTA He le copolymer s corresponding to oAün n IB. f ili de i ^ s a ^ ^ i 1a i ^ ^. ™ p r ""? Lamiria5; ri - > acrylamides and methacrylamides substituted for nitrogen by alcoves 11
interiors, alcohol esters, acrylic methacrylic acids, vinylpyrrolidone or vinyl esters (JJ) Quaternary polymers ae e ~? ei .o os:? a. .as t c Q ñ 37. gives B. A with the no ore ae
«Uru VPFUVI L? pf't VfC T TA O POLYAMINE "in the CT C on i t i ng FA 1 crosslinked .oruro t? e t? e? lio!" P! Vi "! e P" • "" > ! T ^ - ^ 1 i mp i I m, n i / such n the dii and iiaminoet il t t can quaternized by the chloride pía n i 1 A A? O 13 rii iTli a ln
of methyl, the homo or copolymerization being followed by crosslinking by an unsaturation compound i, in particular methylene bis acrylamide. more particularly a copolymer can be used
ammonium (20/80 by weight) in the form of dispersion with 50 u. by weight of said copolymer in mineral oil. This dispersion is marketed under the name of "SALGARE SC 92" by the company ALLIED COLLOIDS. A crosslinked homopolymer of methacryloyloxyethyl trimethylammonium cioride with about 50% by weight of the homopolymer in mineral oil can also be used.This disoersion is marketed under the "SALGARE SC 95" by the company ALLIED
. { ) 1- vy rrss .onicos usable in my invention are poiyalkyleneimine; in? in? m. viniipipamio, conaensaaos de
quaternary and .os derivatives of chitin.
r cntc the polymers chosen from the one to which R, represent the methyl radical, Ai * _ / Bj. represents radical radical of tor- _a - C11_ > - and X "represents the anion l? ~ n - rip? Tri / - nnc rp ri n mA it M vám p '~ lpl cottiputate de fo r p 1a (VII.) n which R i-- R1 represent the ethyl radical, RAJ and R b represent the represent the radical of formula
-. { CH_) 3- and X recre = enta the bromide anion (denominated DOS t er lormente líexc'iußrc * PAK I Among all the cationic polymers that can be used, it is preferred to apply the compounds described above in points (3) and (4) According to the invention, the cationic polymers can represent 0.001% to 10% by weight, preferably from 0.005% to 5% by weight, and even more preferably from 0.01% to 3% by weight, of the weight total of a? m? l A l A nf 1 A 2 1 TT 1 A cosmetically acceptable solvents, different from the propenetrating agent such as onoalcohols,
mixture . Among these solvents, polyethylene glycol, glycerol and sorbitoi may be mentioned more particularly. The solvents are preferably used in proportions of 0.5 to 10% by weight with respect to the total weight of the composition. The pH of the compositions is preferably between 2 and 9 and in particular between 3 and 8. For clobctasol propionate, the pH is conveniently between 5.5 and 6.5. It is adjusted by cosmetically acceptable acidifying agents or acidifying agents.
The compositions according to the invention can also contain other adjuvants used in foaming compositions such as shampoos and especially ceramides, such as those described in French patent FR 2 673 179, glycoceramides, well-known nonionic surfactants which can
* o- c AA rro r- C Q i O- xx T- x t- ~ v? - x 1_ d 3,. 1 Other fatty acids polyethoxy, polypropoxylated or polyglycerolated fatty chain with for example 8 to 18 carbon atoms, with the number rt and i i p r ri p n and i r n p r p? i I p p espe; le lens z number ae ¡c _. to. JU The copolymers of ethylene oxide and of propylene, the condensates of ethylene oxide and of propylene over fatty alcohols can also be mentioned; the polyethoxylated fatty amides with preferably 2 to 30 moles of ethylene oxide, the polyglycerolated fatty amides with an i -r-i-i-1 glycerol and in particular 1.5-yyroxy; the polyethoxylated fatty amines with pre te rcnt emeni to 3 moles of ethylene oxide; the fatty acid esters of sorbitan oxieti reacted with 2 to 30 moles of ethylene oxide; The fatty acid esters, the fatty acid esters of the
1 cs r and rr 1"go * the aiky-glycolicides, the N-alkylaminic derivatives, the amine oxides such as the alkyl (Cic-Cu) amines or the N-acylaminopropyimorpholine oxides, the alkylpolyglycosides and the polyglycerolated fatty acid alcohols The compositions may also contain thickening agents selected in particular from sodium aiginate, gum arabic, cellulose derivatives such as ethyl cellulose, hydroxymethyl cellulose, hydroxyethyl cellulose, hi AA i -n AA il - > (alp > c * a 1 a cr 1 i guar gum or its derivatives, xanthan gums, scleroglucans, crosslinked polyacrylic acids, polyurethanes, acid-based or maleic anhydride copolymers, thickeners associative carriers of natural chain fat chains as the product
PEMÚLEN The thickener can also be obtained by mixing polyethylene glycol and stearates or polyethylene glycol distearates or by mixing phosphoric esters and amides. The compositions according to the invention may also contain dyes, viscosity modifiers, pearlizing agents, moisturizing agents, anti-dandruff agents, anti-seborrheic agents, sunscreens, proteins, vitamins, α-hydroxy acids, salts, perfumes, preservatives, sequestering agents, softeners. , foam modifiers, detcxificantes ossm zcias. Also, conditioning agents such as natural oils ix xlx can be used? u u u u u j, cyclic or fatics, linear or radi- fied (saturated or not, volatile or non-volatile organomodified silicones, soluble or nc, perfumed or fused oils, polybutenes and polyisobutenes, fatty esters that occur in liquid, pasty or solid form, esters of polyhydric alcohols, glycerides, natural waxes and synthetics, silicone gems and resins, quaternary ammonium salts such as the compound classified in the CTFA dictionaries, 7th. In the context of the present invention, the compositions are presented more particularly in the context of the present invention, the term "Quaternium-22" and the name "Ceraph '60", or mixture of these different agents. liquid form, eventual thickened.
They can be used in your state or diluted before use. The compositions according to the invention are more particularly used as shampoos for the treatment of hair or scalp.
In wet or dry hair, then a light massage is preceded by forming a foam, rinsing and eventually applying again the shampoo followed by a nine rinse with water. An object of the invention is also a foaming composition tai as defined above for its application as a medicament. The present invention also has for its object
to the elaboration of a medicine designed to treat the affections of the scalp. compositions according to the invention? n p? p ca a r-ti '..1 u1 1 id vm p A tiA t "AO t O Ai' atation of eczema, of eczematous or psoriatic erderderies, of pruritic lesions, of chronic erythematosus lupus, of psoriasis and plaque parapsoriasis.
These treatments generally require an an l l A A I I I I "5 times a week, and then several illustrative and non-limiting information will be given below.
P \ vr T 'The following shampoo is prepared: - Texapon N7C (Sodium lauryl ether sulfate (2 mol OE) ai 70% M .A.) - Dehyton AB 30"v (? 32% M.a.
- T? Diiscutol '"' (etox idiy 1 icol) 1 u g
- Propionate d ciobetasoi 0.05 g
- Jauuar C162"'(hidi.? Ximetilquai - * i H 1 Ó r- * t" i r ~ r \ cs pH6
Water desminerai_ tadc c 100 g
h T T TvT w T C \
Dehyt? N AB 30"'.ocoiib taina ai 32% M.A.) Jaguar C162" (h.' Dr? Ximeti lyuar t rimet i i amon i o; 0.5 g
Siphon x.0S 225 P "(28% sodium laureth sulfate MA) Ethanol (95/96%) ng Clobetasoid propionate ñ r- ^ g Benzaiconium chloride 0/00 Lactic acid? - SP 6 Demineralised water s 1 0 pg
i_, Ji_, M LO lil frepar, .ente - Texduon N70"(Laurether sulfate from a? di? X / y
- Dehyton AB 30"" '(Cocui lbetaína to 32% M.A.) 6 g
- Transcutol (ethoxydigl icol) 1 0 g
- Adapalene 0.05 g
- Jaguar C162 '(hydr? Ximetilguar trimetiiamonio; u, 5 g cs pH6
- Water P.Liiií-ira iza cs 100 g
GEMPLO IV The following shampoo is prepared: Sipón AOS 225 UP (sodium lauryl ether sulphate at 2% MA) J g- Dehvton AB 30"(Cocoi Ibetaina ai 31% MA) 6 grr, q A 1 (QL Q (Á5- Í 10 g - Benzalkonium chloride 0.01 g
- Jaguar C162". {Hydroxymethyl ura trimethylammonium; 0.5 g-" opionate of - Lactic acid - Demineralized water cs 100 g
T IGlU TTXGI TllTlJTx-? G-, VT The following shampoo is prepared: - Celquat SC 240"(P? Licuaternio 10) 2 g- - Texap? N N70 ^ (Laurylétei bulfato de c AGI i A í / T ?? I p ñTT I al "fj5 'M ü, 1 7 fT
- Dehytoii AB 30"(Cocoylbetaine at 32% M.A.) 6 and
- Rewoquat B50"(Benzalkonium Chloride 50%) 0.01 g - Citric acid, 1H_0 0.24 g
- r -? t- -r ~ - - r? r c ^ i -i 014 *? CI CI
- clobetasol propionate 0.05 g: s 100 Vi The following shampoo is prepared: - Celquat SC 240 (Poiicuaterni? 10) 2 g- - Texap? N N70 (Lauriieter sodium sulfate (2 moles OE, 70% MA ) 17 g - Dehyton AB 30"(Cocoi Ibetaina at 32% MA) 6 g Re oquat B50" (Clururu of benzalkonium 50%) 0, 01 g Ethanol (95/96%) 10 g
- Propionate of 0.05 g
- Water des ineralizada csp 100 g
EXAMPLE VII The following shampoo is prepared: - sodium citrate, 2H_0 2.6 g 'arahidroxybenzoate 0.1 g- - Celqudt SC 240"(Pultrude nio 10) g- - Texapon N70 (Sodium lauryl ether sulfatu (2 moles OE) at 70% M.xA.) 17 g
- Dehyt? P AB 30"(C? C? Ilibin 32% M.A..)) O g
- Propionate of L /, J ^ g - Water p? U? V-? t? . "a p csp 100 g
LULlhl JJU l X x. X The following shampoo is prepared: - Citric acid, 0.24 g - Sodium citrate 2.6 g
- Ceiquat SC 240 (P? Licuaterni? 10) 2 g- - Texapon N70"(Sodium laurylétei sulphate (2 moles OE) at 70% M.A.) 17 g - Dehyton AB 30" "(32% cocoylbetaine M.A.) 6 g
- clobetasol propionate 0.05 g
- ¿Tapoi 'i / yóíí i * g
- Purified water csp 100 g
EXAMPLE IX The following shampoo is prepared: - Jaguar 0162 ^ (hydrimethyl trimethyl ammonium) 0.5 g - Qui exano HC (32% cocoylbetaine M.A.) 6.0 g
- Sipón AOS 225 UP "(sodium lauryl ether sulfate ux 1 x ~ - p 5? - T xvxf.A • / I 43, 0 g x_> g? X_ \ gt; ~> / _? / 10, 0 g
- "xDt_ n_jJJAxi ./- A -? Dr? R cs r L * x? C i-uüux 0, 05 g - e ocjuat B50 (Benzalkonium Chloride 50%) 0.01 g 100 g
The following shampoo is prepared: - Jaguar CI62"(hydr? Xime ilguar trimetiiamonio) 0.5
- Texapun N70"(Sodium lauryl ether sulphate (2 moles OE) at 70% M.xzv.) 17 g
- Dehyt? N AB 30"(C? C? Ilbetaine at 32% M.A.) 6 g - Rew? UuaL R50" (Benzalkonium chloride 50%) 0.01 g 3y
Ethanol (95/96%) g
Adapalene g
Demineralized water 100 g
tr TT7M-DT r \ Y T The following shampoo is prepared - Jaguar Cl 62"(hydroxim tilguar 0,
- Texapon N70"(Sodium lauryl ether sulfate (2 moles OE) at 70% M.? A ?.) g
- Dehyton AB 30"(C? Coylbetaine ai 32% M.A.) or g
- Rew? Quat B50"(Benzalkonium Chloride 50%) 0.01 g
- V i r "a a! O / Q £. ° - i 10 g
- To L ^ _? _ U? / (j. ad rp.ant? -6-methox? ethoxy? methox? - '-naphthyl] benzoic 0.05 g csp 100 g
t? TT7MDT Cl Y T T The following shampoo is prepared: - Jaguar C162"(hydr? Xiipe t íiguar trimotilamonio) 0, 5
- Texapori N70 (Sodium lauryl ether sulfate (2 moles OE) ai 70% M.A.) 17 g
- Dehyt? N AB 30 * (C? Coiibetaína to 32% M.A.) 6 g
- Rewoquat B50 (Chloride and beiizalc? Ni? 50%) 0.01 g - Ethanol (95/96%) - 2-Hydroxy-4- [3-OXO-3- i -methoxy-pl] -l-propynyl acid ] ben. - Demineralized water csp 100 g
EXAMPLE XIII The following shampoo is prepared: - Jaquar C162"(hydroxy etiiguar trimethylammonium) 0.5 g
-. 10 - Texapon N70"(Sodium lauryl ether sulphate { 2 m or 1 is OE) ai 70% A.) 17 g
- Dehyt? N AB 30"í C? Coiibetaína to 32% M.A.) 6 g
- Rew? Quat B50"(Benzalc? Ni? 50% Chloride) 0.01 g
- Etapoi '95 / 96V1 10 g l -í - 7l A i A A A -. { ~ o The following shampoo is prepared: - Texapon N70 (Sodium iiiiétei sulfate and 2 moles OE) at 0% M.A.) 17 g
- Dehyton AB 3C TTocoi Ibe taina at 32% M.A.) 6 g
- Methocel E4M (? Rox? Propyl metli cellulose) 1 g 1H_0 0.24 g - 2H20 sodium citrate, or g
- Cerafil 60 (Quaternium 22) 0.5 g
- clobetasoi propionate 0.05 g
TTr? ^ DA? XxA xI-? Q? / Q 10 g
- Demineralized water cs 100 g
The compositions of the aforementioned examples I to XIV are stable during storage and have a satisfactory foaming effect. A clinical study in which a composition according to example IX was used as a shampoo, once a day for two weeks applied to wet hair and left in contact for 10 minutes, to be rinsed, allowed to be observed in affected patients. psoriasis, a reduction in the level of the scalp of the erythema in 37%, of the ae: r ae. hyperkeratosis in 50% see the pruritus in a 3 'or
It is noted that in relation to this date, the method known to the applicant to carry the invention is the conventional one for the manufacture of the objects or products to which it refers.
Claims (10)
- Having described the invention as above,za < Foaming composition for washing and treating the hair and / or the scalp, characterized in that it contains in an aqueous medium: at least one active ingredient selected from corticosteroids and retinoids, - at least one anionic surfactant, less an amphoteric surfactant and a propenetrating agent.
- 2. Composition according to claim 1, characterized in that the corticosteroids are chosen from among the diprcpionate of alclometasone, amcinonide, becylammethasone dipropionate, betamethasone benzoate, betamethasone dipropionate, betamethasone valerate, budesonide, propionate. of clobetasol, preferably clobetasoi propionate, clobetasol butyrate, desonide, deoxyethasone, dexamethasone, di-florasone diacetate, di-flucortolone valerate, fiurandrenolone, fiuprednidene acetate, fluocortolone, fluocortin butyl, fluocinonide, fluocinolone aceto ida, fluclorolone acetonide, flumethasone pivalate, feudilma hydrochloride, flumetolone, halcinonide, hydrocortisone, hydrocortisone acetate, hydrocortisone butyrate, hydrocortisone valerate, methylprednisolone acetate, mometasone furoate, methylprednisolone, prednisolone, acetonide a lamcinolone, or between mixtures pharmaceutically > acceptable from the latter.
- 3. Composition according to claim 1 or 2, characterized in that the retmoids are chosen from the t-trans retinoic acid, adapalene, isotretinoin, retinol and its derivatives, such as acetate, palmitate or propienate. retine !, the motretmide, the etretinate, the acitretma, the t-trans zinc retinoate, the arotinoids, the synthetic retinoids or between pharmaceutically acceptable mixtures of the latter. or
- 4. Composition according to claim 1 or 2, characterized in that the active principle is chosen among the clobetasol 17-prcpionate, adapalene, 4- [7- ladamantyl) -6-ethoxy-zefox-methox? -2-naphthyl] benzoic acid, 2-h? Drox? -5-4- [3-oxo-3- (3-tert-butyl-4-methoxyphenyl) -1-propynyl] benzoic acid and 4-hydroxy acid (3, 5, 5, 8, 8, -péncame i _ 5,6,7, 8-tetrahidrc -2 -naftiltio) benzoico. Composition according to any one of Claims 1 to 3, characterized in that the anionic surfactants are selected from the salts of the following compounds: alkyl sulfates, alkylene bisphosphates, alkyl sidoethersulfates, alkylaryl polyether sulfates, onions and the like. sulfates, the alkyphosphonates, the1U1Ai Al uri! S, aiquiiapisuitonatos, a-olefin-sulphonates, paraffin < sulfonates, acids, succinatides, alkyl sulphides, alkylsulfoacetates, aikido-phosphates, osmagents, aci. and the N-acyltaurates, and between the salts of the oieic, ricinoleic, palmitic, stearic acids, the copra oil acids or the hydrogenated copra oil, the acyl lactylates; and among the acids of iia niaceae uroniecs and their salts, as well as the polyoxyalkylenated carboxylic alkyl (C "-C_,) ether carboxylic acids, the polyoxyalkylenated alkyl aryl ether carboxylic acids, the alkyl CC \ pmi A? Polyoxyalkylenated carboxylic ether and its 6. Composition according to any of claims 1 to 5, characterized in that the anionic surfactants are chosen from the salts of aiquilsulfatbs and alkyl ether sulphates. Composition according to claim 6, characterized in that the anionic surfactants are chosen from sodium lauryl ether sulphate and sodium lauryl sulfate. 8. Composition in accordance with any10 of claims 1 to 7, characterized in thataliphatic secondary or tertiary amines, (C -C2 betamas, sulfobetaines, alkyl) amidoaikyl (C.-C betaines and alkyl (Cj-C_v)9. Composition according to any of claims 1 to 8, characterized in that the aforementioned thickeners are chosen from among the claims of claim 1, characterized in that the amphoteric surfactants are chosen from the cocamidopropyl betaines, the cocamidopropylhydroxy suitaine, the cocoylbetaines. 11. Composition according to any one of claims 1 to 10, characterized in that the propenetrating agent is chosen from the alcohols which are volatile in Ci-C4 and between the polyhydric alcohols. 12. Composition according to any of claims 1 to 11, characterized in that the propenetrating agent is chosen from ethanol, isopropane, propiienglycole and ethoxydiglycol. 13. Composition according to any of claims 1 to 12, characterized in that the r > v? ^ i r > ia * - f- i to 1 ~ "1 in ratio of 0.001 au, preferably between 0.01 to 0.3% and more preferably between 0.05 and 0.18 in weight with respect to the total weight of the composition 14. Composition in accordance with any of the characteristics characterized because the t e11 = iu ac 11vo used in proportions of o re < -ent between 30% and more em and:;.)% ac .A. By weight with respect to the 15. C '"1"' - osition according to any one of claims 14, characterized in that the n ¡nns? I 1 anza li za; in proportions of0.01 and 30%, preferably between 0.5 and 20% and more preferably -nrre 1 and 15% in M.A. of weight with respect to the total weight of the composition.16. Composition according to any of claims 1 to 15, characterized in that the propenetrating agent is used in concentrations of between 0.1 and 25% and preferably comprised between 5 and 10% by weight with respect to the total weight of the composition. 17. Composition according to any of claims 1 to 16, characterized in that the ratio between the proportions in M.A. of the anionic and amphoteric surfactants is comprised between 1 and 20 and preferably between 2 and 10. Composition according to any of claims 1 to 17, characterized in that the ratio between the proportion in M.A. of the anionic surfactants and the proportion of the propenetrating agents is between 0.1 and 10, preferably between, and. Composition according to any one of Claims 1 to 18, characterized in that the composition also contains cationic polymers chosen from quaternized proteins, polymers of the polyamine, polyaminoamide, quaternary polyammonium type, polyalkyleneimines, polyamine condensates and epichlorohydrin quaternary polyureylenes and chitin derivatives.ae reivinations i to 19, characterized in that the cationic polymers are chosen from the ether derivatives of quaternary celluloses, the cyclopolymers and the21. Composition according to claim 19 to 20, characterized in that the cationic polymer represents 0.001% to 10% by weight, preferably from 0.005% to 5% by weight, and even more preferably from 0.01% to 3% by weight with respect to the total weight of the final composition. 22. Composition according to any of claims ia 21, characterized in that the pH of the compositions is between 2 and 9, preferably between 3 and 8 and more preferably between 5 and 6, 5. 23. Composition in accordance with any from Claims 1 to 22, characterized in that the composition also contains nonionic surfactants and / or ceramides and / or glycoceramides. 24. Composition according to any of claims 1 to 23, characterized in that the composition contains thickening agents. 25. Composition according to any of claims 1 to 24, characterized in that the composition also contains dyes, viscosity modifying agents, nacreous agents, moisturizing agents, anti-dandruff agents, antiseborrhoeic agents, sunscreens, proteins, vitamins, a-hydroxy acids ,
- 5 salts, perfumes, preservatives, sequestrants, softeners, foam modifiers, detoxifiers or their mixtures. 26. Composition according to any of claims 1 to 25, characterized in that iaThe composition also contains conditioning agents such as hydrogenated or non-hydrogenated natural oils, linear or branched (saturated or non-saturated), silicones, whether volatile or not, organomodified or not, soluble or not, perfumed or fluorinated oils, polybutenes and polyethylene. sec es, fatty esters which are present in liquid, pasty or solid form, the esters of polyhydric alcohols, glycerides, natural or synthetic waxes, gums and resins of silicones, quaternary salts or the composition according to claim 26. , characterized in that the composition also contains quatern? -22 28. Composition according to any of claims 1 to 27, characterized in that it is in the form of liquids, possibly thickened 29. Composition according to any of the claims 1 to 28, for application as a medicament 30. Use of the composition as defined in any of the claims. 1 to 28, for the elaboration of a medicament intended to treat the affections of the scalp.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR98/07802 | 1998-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA00012577A true MXPA00012577A (en) | 2001-09-07 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7700081B2 (en) | Foaming compositions for hair care | |
JP3237853B2 (en) | Compositions for treating hair or skin | |
JP2001206823A (en) | Composition for cleansing keratin substance, ethoxylation comprising weakly ethoxylated sorbitan ester as base | |
US20030086953A1 (en) | Use of amphoteric surfactants in cosmetic compositions to precipitate cationic polymers on dilution | |
KR20020060231A (en) | Modified starch solutions and their use in personal care | |
JP3602862B2 (en) | Conditioner for keratin substances | |
JP3843051B2 (en) | Shampoo composition | |
JPH0341015A (en) | Hair cosmetic | |
JPH03275614A (en) | Hair preparation | |
JP3395488B2 (en) | Hair cosmetics | |
JP2002505260A (en) | Highly alkaline hair compositions that increase richness and swelling | |
JP2003073257A (en) | Skin cleanser composition | |
US5900232A (en) | Cosmetic compositions containing at least one anionic surfactant of alkylgalactoside uronate type and at least one cationic polymer, and uses thereof in the treatment of keratinous substances | |
JPH0460565B2 (en) | ||
JP2640599B2 (en) | Hair deforming agent and method | |
MXPA00012577A (en) | Foaming composition for hair care | |
BR9914335B1 (en) | Hair care makeup that produces volume. | |
JPH0240315A (en) | Composition based on amphoteric surfactant and pyrimidine derivative | |
GB2220216A (en) | Washing and conditioning hair | |
JP2003300813A (en) | Cosmetic | |
JPH07215829A (en) | Hair deforming agent composition | |
US20030139502A1 (en) | Cosmetic compositions comprising a cationic polymer/anionic surfactant mixture and use of said mixture as conditioning agent | |
JP2567316B2 (en) | Hair cosmetics | |
JP2002284628A (en) | Cosmetic composition | |
JP2024120647A (en) | Aqueous composition for treating textiles or keratinous materials |